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The present investigation was undertaken to evaluate the possible ocular phototoxicity of drugs used in 
ophthalmic formulations. Sulphacetamide, ketoconazole, voriconazole, diclofenac, and ketorolac were 
assessed in the concentrations available in the market for their ocular use. The suitable models viz Hen’s 
Egg Test Chorioallantoic Membrane (HET-CAM) test, Isolated Chicken Eye (ICE) test, and Red Blood 
Cell (RBC) haemolysis test as recommended by ECVAM, ICCVAM, and OECD guidelines were performed. 
Results of HET-CAM and ICE tests suggest that sulphacetamide is moderately toxic in the presence of 
light/UV-A and very slightly irritant without irradiation. Ketoconazole and voriconazole were found slightly 
irritant in presence of light/UV-A and non-irritant in dark. Diclofenac and ketorolac demonstrated slight 
irritancy in the light and were found to be non-irritant in dark. The results suggest that some of the drugs 
have potential toxic effect in the presence of light. The extent of phototoxicity might get extended when 
used for longer time. The recommendation is that these drugs should be stored and used in the dark for a 
specified time and be labelled with specific instructions for patients, especially for those working longer 
in the sunlight.
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In the regulatory context the term ‘eye irritation’ 
is generally defined as the development of undesirable 
changes in the eye after the application of a test 
substance to the anterior surface of the eye, which are 
reversible within 21 days of treatment. The Organisation 
for Economic Co-operation and Development (OECD) 
defined the substances that cause reversible tissue 
changes to the eye as ocular irritants and severity of 
the irritancy depends on the change/damage to the eye 
caused by the substance (1). The changes that are not 
reversible over the mentioned period are classified as 
ocular corrosives. The toxic reaction/ocular corrosion 
develops due to photodegradation of pharmaceutically 
active compounds or sometimes excipients present in 
ocular formulations when exposed to UV radiations 
(2, 3).
Antibacterial agents either alone or in combination 
with non-steroidal anti-inflammatory drugs (NSAIDs) 
are the first line therapy for ophthalmic use. Among 
these, drugs such as sulphacetamide, ketoconazole, 
voriconazole, diclofenac, and ketorolac are frequently 
used. This investigation is an attempt to examine 
ocular phototoxicity of the above mentioned drugs 
that show photodegradation but no data has been 
available to support this. Five drugs primarily 
belonging to the category of antibacterial agents and 
NSAIDs, intended for ocular use, were investigated 
for their possible irritancy/toxicity to the eye, using 
158
the methods approved by international regulatory 
agencies viz the OECD, International Coordination 
Committee for the Validation of Alternative Methods 
(ICCVAM), and European Centre for the Validation 
of Alternative Methods (ECVAM).
MATERIALS AND METHODS
Chemicals
Sodium sal t  of  sulphacetamide (N-[(4-
aminophenyl)sulfonyl]acetamide) (CAS number- 144-
80-9) was obtained from East India Pharmaceutical 
Works Limited, Kolkata, India as a gift sample. 
Ke toconazo le  (1 - [4 - (4 -{ [ (2R,4S) -2 - (2 ,4 -
Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-
dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethan-
1-one) (CAS number 65277-42-1) was procured from 
Biochemix Pharmaceuticals, Haryana, India. 
Voriconazole ((2R,3S)-2-(2,4-difluorophenyl)-3-(5-
fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-
2-ol) (CAS number 137234-62-9) was procured from 
Auro Labs, Tamil Nadu, India as sterile lyophilised 
dr ied  powder.  Sodium sal t  of  d ic lofenac 
(2-(2-(2,6-dichlorophenylamino)phenyl)acetic acid ) 
(CAS number 15307-86-5) was procured from Zee 
Labs Limited, Haryana, India and ketorolac 
tromethamine ((±)-5-benzoyl-2,3-dihydro-1H-
pyrrol izine-1-carboxylic  acid,  2-amino-2-
(hydroxymethyl)-1,3-propanediol) (CAS number 
74103-07-4)  was obtained from Sun Pharma Limited, 
M u m b a i ,  I n d i a .  F l u o r e s c e i n  s o d i u m 
(3’,6’-dihydroxyspiro[2-benzofuran-3,9’-xanthene]-
1-one) (CAS number 2321-07-5) was obtained from 
Garuda Chemicals, Mumbai, India. Sodium chloride 
(Loba Chemie, Mumbai India) (0.9 %) and sodium 
hydroxide (Loba Chemie, Mumbai, India) (0.1 %) 
(Loba Chemie, Mumbai India) were used as negative 
and positive controls in all the tests performed. Sodium 
hydroxide is recommended to be used as positive 
control in standard protocols (4-6). Concentrations of 
drugs for the experiments were decided according to 
the concentrations available in the market. Three 
concentrations of each drug were freshly prepared in 
normal saline before the experiment: sulphacetamide 
(10, 20, and 30 % w/v), ketoconazole (1, 2, and 3 % 
w/v), voriconazole (0.5, 1, and 1.5 % w/v), diclofenac 
(0.05, 0.1, and 0.15 % w/v), and ketorolac (0.2, 0.4, 
and 0.5 % w/v). The highest concentration of each 
drug was made with an intention to observe the toxic 
profile at higher concentrations as these concentrations 
might be or might not be available in many countries’ 
markets.
Toxicity testing
Hen’s Egg Test, Isolated Chicken Eye Test, and 
Red Blood Cell Lysis test were applied to profile the 
possible toxicity of selected chemicals. The methods 
have been approved by various national and 
international regulatory agencies like ICCVAM, 
ECVAM and the Japanese Centre for the Validation 
of Alternative Methods (JaCVAM). These agencies 
are primarily working with the objective to develop 
and validate methods that are an alternative to the 
existing animal experiments and are not related to 
ethical issues. The selected methods are based on 
animals that are available in slaughterhouses (eggs 
from egg farms and chicken from local slaughterhouses) 
and consumed as food. Hence no ethical issues are 
concerned with our investigation.
Hen’s Egg Test (HET-CAM Test) 
Chicken eggs were procured from local poultry 
and egg hatching farm at Lucknow, India. Fresh (not 
older than seven days), fertile, and clean eggs 
weighing between 50 and 60 g were used. Eggs were 
candled prior to use and nonviable or defective eggs 
were discarded. Excessively misshapen eggs or eggs 
with cracked or thin shells were not used. Eggs were 
placed in the incubator at 37±0.5 °C and 60±2 % 
relative humidity. The day on which the eggs were 
placed in the incubator was considered as day one. 
Hand rotation was carried out five times per day until 
the day eight. Four eggs for each concentration of each 
case (light and dark) were grouped [total eggs = 4 
(each concentration) x15 (concentrations) x2 (light 
and dark)=120 eggs were successfully grouped]. On 
day nine, eggs were removed for the assay. The region 
of air cell was cut and membrane was pared off. Using 
0.9 % NaCl, membrane was moistened using a 
disposable glass pipette. Eggs were placed in the 
incubator for 30 min. The inner membrane was 
carefully removed with forceps. Approximately 0.3 
mL of tested substances was placed directly onto the 
clear Chorioallantoic Membrane (CAM) surface. The 
surface was observed for changes for 5 min (300 s) 
by taking photographs (Canon EOS 1100D Camera, 
12.2 x) at different time points (0, 60, 120, 180, 240, 
and 300 s). Endpoints (surface changes) that were 
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observed were: haemorrhage (bleeding from the 
vessels); vascular lysis (blood vessel disintegration); 
and coagulation (intra- and extra-vascular protein 
denaturation).
The UV-A light (10 watts, Phillips, India) was used 
to evaluate possible phototoxicity. UV-A bulb was 
assembled inside the incubator where the temperature 
was maintained. The scoring of surface changes was 
carried out according to the scoring table given in the 
protocol (Table 1). The observations of surface 
changes were translated into quantitative scoring 
system using Irritation Score (IS) formula given below 
(4):
 Haemorrhage time = observed start (in seconds) 
of haemorrhage reactions on CAM 
Lysis time = observed start (in seconds) of vessel 
lysis on CAM 
Coagulation time = observed start (in seconds) of 
coagulation formation on CAM  
Phototoxicity index was also measured using the 
formula (7):
Phototoxicity index= {[Mean score (light)-Mean 
score (dark)]/Mean score (dark)}x100
Isolated Chicken Eye Test (ICE Test)
Chicken eyes were collected from chickens 
obtained from local slaughterhouse at Lucknow, India, 
where they are killed for human consumption (chicken 
used in the study were approximately seven weeks old 
weighing approximately 1.5-2.5 kg). Only the eyes of 
healthy animals considered suitable for entry into the 
human food chain were used. Eyes were isolated from 
the eye socket without any damage. A drop of sodium 
fluorescein 2 % w/v was put onto the corneal surface 
for 10-20 s, and then immediately rinsed with 20 mL 
isotonic saline. Cornea was examined for potential 
damage. The final number of eyes used was 120 
(groups and number of subjects were same as in the 
HET-CAM Test). Each eye was placed in an absorbent 
pad and the nictitating membrane was cut as well as 
other connective tissue. Eyes were placed in a 
superfusion chamber at a temperature of 32 °C with 
water pump according to the OECD ICE test 
protocol-438 (6). The entire cornea was supplied with 
isotonic saline from a bent stainless steel tube at a rate 
of 0.10-0.15 mL min-1 via a peristaltic pump. Once all 
eyes have been examined and approved, they were 
placed at 32±1.5 °C for 45-60 min to be equilibrated 
to the test system prior to dosing. The whole system 
was kept in an incubator to maintain the temperature. 
After the equilibration period, a zero reference 
measurement was recorded for corneal thickness and 
corneal opacity to serve as a baseline (i.e., time = 0). 
The fluorescein retention score determined at 
dissection was used as the baseline measurement. 
Liquid test substance was applied at 0.03 mL with a 
micropipette so that the entire surface of the cornea 
was evenly covered. Test material was applied for a 
total of 10 s and then rinsed with 20 mL isotonic saline 
at room temperature. After the rinse step, the eye was 
returned to the superfusion apparatus. Treated corneas 
were evaluated prior to treatment and starting at 0, 30, 
60, 90, 120, 150, 180, 210, 240 min (±5 min) after the 
post-treatment rinse. The endpoints evaluated were 
corneal opacity, swelling, and fluorescein retention. 
Corneal swelling was determined from corneal 
thickness measurements made with an optical 
pachymeter (PachPen Pachymeter, Accutome, The 
Netherlands). It is expressed as a percentage and is 
calculated from corneal thickness measurements 
according to the following formula (5):
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Table 1 Classification scheme for irritation score in HET-CAM Test
Photochemical damage Score Irritancy level
No visible membrane discoloration Up to 0.9 Practically none
Just visible membrane discoloration 1-4.9 Slight
Visible membrane discoloration/haemorrhage, 
structures are covered partially 8-8.9 Moderate
Visible membrane discolouration/ haemorrhage, 
structures are entirely covered 9 and above Strong
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The mean percentage of corneal swelling for all 
test eyes was calculated for each observation time 
point. Based on the highest mean score for corneal 
swelling, as observed at any time point, an overall 
category score is then given for each test substance. 
Corneal opacity is calculated by using the area of the 
cornea that is most densely opacified for scoring. 
Pictures of eyes were taken (Canon EOS 1100D 
Camera, Taiwan, China) and the opacity was observed 
visually. The mean corneal opacity value for all test 
eyes was calculated for each observation time point. 
The test was performed as dark and light groups (light 
specifications were kept identical to the HET-CAM 
Test). The mean fluorescein retention values for all 
test eyes were observed for the 30-min observation 
time point. Scoring of opacity and fluorescein retention 
was carried out using standard scoring tables (Table 
2 and Table 3) (5).
Red Blood Cell Haemolysis Test
Fresh blood samples taken from hens weighing 
2 kg were obtained from the local slaughter house 
(Lucknow, India). Blood samples were kept in tubes 
containing 3.2 % sodium citrate (SD Fine Chemicals, 
Mumbai, India) solution as anti-coagulating agent. 
Repetitive centrifugations at 2000 rpm (approx. 3757 
g) for 10 min (Remi CPR-30 Plus, Mumbai, India) 
were carried out to remove plasma, white blood cells 
(WBC), and to separate red blood cells (RBC). Citrate 
buffer (SD Fine Chemicals, Mumbai, India) was used 
to store the RBCs and prevent coagulation and was 
used as a vehicle for RBC suspension. RBC was stored 
at -20 °C until use. The principle of this method is that 
the addition of a toxic chemical in RBC solutions 
causes RBC lysis and the haemoglobin released is 
measured at particular wavelength using colorimeter. 
Various concentrations of test samples in phosphate 
buffer saline (PBS) were incubated with a defined 
quantity of RBC suspension for 10 min with constant 
shaking, at room temperature. The incubation period 
was terminated by high speed centrifugation. The 
resul t ing supernatant  was then monitored 
photometrically at 530 or 560 nm (Photocolorimeter 
1313, Environmental and Scientific Instruments Co., 
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Table 2 Corneal opacity scores
Score Observation
0 No opacity
0.5 Very faint opacity
1 Scattered or diffuse areas; details of the iris are clearly visible
2 Easily discernible translucent area; details of the iris are slightlyobscured
3 Severe corneal opacity; no specific details of the iris are visible; size of the pupil is barely discernible
4 Complete corneal opacity; iris invisible
Table 3 Fluorescein retention scores
Score Observation
0 No fluorescein retention
0.5 Very minor single cell staining
1 Single cell staining scattered throughout the treated area of the cornea
2 Focal or confluent dense single cell staining
3 Confluent large areas of the cornea retaining fluorescein.
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Haryana, India) against the blank. The total 
haemoglobin release by positive control was taken as 
100 % and the tests were evaluated relative to that. 
The corresponding concentration at the 50 % response 
was considered as H50 value.
Protein Denaturation Test
A 1 % solution of test in PBS was incubated with 
defined quantity of RBC suspension for 10 min with 
constant shaking at room temperature. The resulting 
supernatants were monitored at 575 and 540 nm 
respectively. The relation between the effective 
concentration of 50 % haemolysis and protein 
denaturation (relative to sodium dodecyl sulphate 
denaturation) is known as Lysis/Denaturation Ratio 
(L/D) (8). The results obtained were compared for 
each case as per the evaluation table given in the 
protocol (8). The test was performed as dark and light 
group. The irritancy level was scored using standard 
scoring table (Table 4) (8).
Statistical analysis
All data were expressed as mean scores (Mean ± 
SEM, n=4). For the statistical comparison the results 
were compared with negative and positive controls 
using Dunnett’s Test (**P<0.01, *P<0.05 were 
considered as significant levels). Mean values of light 
and dark cases were compared using student’s t-test. 




Image recordings were carried out at different time 
points to observe the changes on the membrane (Figure 
1). For sulphacetamide, mean irritation scores in light 
case were 4.9, 7.7, and 9.8 for 10, 20, and 30 % w/v 
respectively, indicating the concentration dependent 
irritancy. For ketoconazole these values were 5.8, 5.4, 
and 5.8 at 1, 2, and 4 % respectively. For voriconazole 
the classification was slight, moderate, and slight 
irritancy while in diclofenac moderate, slight, and 
slight irritancy were observed. On the contrary, 
ketorolac demonstrated slight irritancy at all the 
concentrations tested (Table 5). In all treatments, the 
mean irritation score was found to be higher in light 
in comparison to dark case.
ICE Test
Results from light case suggest the irritant potential 
of sulphacetamide, in a concentration-dependent 
manner. Ketoconazole showed moderate, slight, and 
moderate level of irritancy at 1, 2, and 4 % w/v 
concentration respectively. Voriconazole showed very 
slight level of toxicity at 0.5 and 1.5 % concentrations. 
Slight level of irritancy was observed in case of 
diclofenac as well. Ketorolac was found to be very 
slightly irritant at 0.2 and 0.5 % w/v concentrations 
respectively (Table 6).
RBC Test
None of the drugs were found to be haemolytic at 
all concentrations tested in both light and dark cases 
in the RBC test. Haemolysis was observed at very 
high concentrations of tested drugs (Table 7).
Combined phototoxicity classification
Combined data comparison (Table 8) suggest that 
drugs show their possible phototoxicity on HET-CAM 
and ICE tests only but not on RBC test at the used 
concentrations. This investigation suggests that drugs 
exhibit phototoxicity potential at the concentrations 
that are available in the market.
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Table 4 Irritancy level classification in RBC test (8)








Phototoxicity is an important concern that must be 
considered prior to drug prescription/administration. 
It might cause severe cellular damage and disrupt the 
normal function of tissue/organ. Cells that are stressed 
(loaded with multiple functions at a time) and 
continuously change their function are more sensitive 
to phototoxicity (9).
Most of the antibacterial agents and NSAIDs 
including sulphacetamide, ketoconazole, voriconazole, 
diclofenac, and ketorolac are reported to get sensitised 
and degraded in the presence of light which might 
cause irritation leading to toxicity upon continuous 
usage (10-16). As we found, very few studies available 
suggested the  possible phototoxicity of the investigated 
drugs and there were no suitable studies to validate 
this problem. Most of the studies were carried out by 
chemical analysis groups. Literature review suggested 
that the extent of phototoxic side-effects of these drugs 
depends upon their chemical structure, absorption 
spectra, binding of the drug to tissue, and the ability 
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Table 5 Mean score values and irritancy classification (4) of drugs (HET-CAM Test)














(NaCl, 0.9 %) 0 None 0 Slight None
Positive control 
(NaOH, 0.1 %) 11.8±0.8 Strong 19.0 Strong 0.60
Sulphacetamide (10 %) 1.6±0.52 Slight 4.9±0.44** (s) Slight 2.10
Sulphacetamide (20 %) 2.4±0.19** Slight 7.7±0.62** (s) Moderate 2.24
Sulphacetamide (30 %) 3.5±0.39** Slight 9.8±0.29** (s) Strong 1.77
Ketoconazole (1 %) 1.1±0.35 Slight 5.8±0.24** (s) Moderate 4.06
Ketoconazole (2 %) 0.6±0.35 None 5.4±0.39** (s) Moderate 7.44
Ketoconazole (4 %) 1.8±0.42* Slight 5.8±1.5** (s) Moderate 2.25
Voriconazole (0.5 %) 1.2±0.40 Slight 4.4±0.86* (s) Slight 2.69
Voriconazole (1 %) 1.1±0.67 Slight 6.4±0.64** (s) Moderate 4.70
Voriconazole (1.5 %) 2.2±0.24** Slight 4.0±0.85* Slight 0.84
Diclofenac (0.05 %) <0.1 None 5.4±0.67** Moderate 76.78
Diclofenac (0.1 %) <0.1 None 4.6±0.99** Slight 65.35
Diclofenac (0.15 %) <0.1 None 1.9±1.2 Slight 25.71
Ketorolac (0.2 %) <0.1 None 1.7±0.97 Slight 23.21
Ketorolac (0.4 %) 0.4±0.2 None 8±1.6 (s) Slight 5.59
Ketorolac (0.5 %) 0.8±0.5 None 2.8±1.6 Slight 2.27
Statistical significance compared to negative control using Dunnett’s test. *P<0.05, **P<0.01.
IS = Irritation Score; (s) = significant difference between dark and light mean values (Student’s t test)
Figure 1 Images of HET-CAM Test (Light case): (A) Normal 
(B) Toxic






































































































































































































































































































































































































































































































































































































































































































































































































































































































































to cross blood-ocular barrier (17). It is worthwhile to 
mention that the literature is available to suggest the 
photosensitivity of these agents; however no literature 
elaborates on the ocular toxicity of these agents. The 
present study was undertaken to evaluate ocular 
phototoxicity of these drugs.
Sulphacetamide displayed ‘slight’ irritation 
potential in HET-CAM test (dark) in a concentration 
independent manner. However, in light case it showed 
concentration dependent toxicity and reached ‘strong 
irritant’ category at higher concentrations. These 
results suggest that in the presence of light, 
sulphacetamide is more toxic than in the dark, 
depending on the concentration. In ICE test similar 
results were observed except that the extent of toxicity 
was lower than in HET-CAM test. In the presence of 
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Table 8 Combined phototoxicity classifications
Treatment HET-CAM ICE RBC
Sulphacetamide (10 %) Slight None None
Sulphacetamide (20 %) Moderate Slight None
Sulphacetamide (30 %) Strong Moderate None
Ketoconazole (1 %) Moderate Slight None
Ketoconazole (2 %) Moderate Moderate None
Ketoconazole (4 %) Moderate Slight None
Voriconazole (0.5 %) Slight Slight None
Voriconazole (1 %) Moderate Moderate None
Voriconazole (1.5 %) Slight Slight None
Diclofenac (0.05 %) Very slight Very slight None
Diclofenac (0.1 %) Very slight Very slight None
Diclofenac (0.15 %) Very slight Very slight None
Ketorolac (0.2 %) None None None
Ketorolac (0.4 %) Very slight Very slight None
Ketorolac (0.5 %) Very slight Very slight None

























control None 0 0 None None 0 0 None
Positive control 0.92 59 0.016 Irritant 0.63 96 0.0 Very irritant
Sulphacetamide Very high Very high
Very 
high None Very high
Very 
high 1.98 None 
Ketoconazole Very high 5.79 Very high None Very high 15.31
Very 
high None 
Voriconazole Very high 3.48 Very high None Very high 9.65
Very 
high None 
Diclofenac Very high 2.56 Very high None Very high 5.33
Very 
high None 
Ketorolac Very high 5.23 Very high None Very high 7.26
Very 
high None 
H50 – haemoglobin release at 50 % in Red Blood Cell Haemolysis Test, DI – denaturation index
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light, sulphacetamide exists in triplet state and releases 
electrons. It produces SO, C6H4SO2, and NHR radicals 
(10). Photodegradation is reported to occur through 
the supply of hydrated electrons to the tissue. These 
electrons interfere with bimolecular biosynthesis and 
cause cellular damage and modifications like 
depolymerisation of hyaluronic acid (11). These 
intermediate radicals have the ability to cause 
phototoxic and photoallergic effects, as observed in 
our study (12, 18).
Ketoconazole was found to be ‘moderately irritant’ 
at all concentrations in HET-CAM test whereas in ICE 
it displayed ‘slight’ to ‘moderate’ effect at different 






piperazine (13). Possible mechanisms to explain 
ketoconazole phototoxicity include generation of 
singlet oxygen, superoxide anion radical, and other 
free radicals which cause cellular damage (14). 
Ketoconazole is said to lose its pharmacological 
activity after photodegradation (19).
Voriconazole also exhibited results similar to 
ketoconazole in HET-CAM and ICE tests. Voriconazole 
is reported to produce 1-(2, 4-difluorophenyl)-2-
(1H-1, 2,4-triazol-1-yl)-1-ethanone as the main 
photodegradation product and its major metabolites 
are di-hydroxyl and N-oxide metabolites (20). Reports 
are available on the skin phototoxicity of voriconazole 
which suggest that the most likely mechanisms of its 
phototoxicity are related to either voriconazole 
(superoxide anion radical, singlet oxygen) or its 
N-oxide metabolite, and retinoidal metabolic 
interference (15, 21, 22).
Diclofenac and ketorolac have shown slight 
irritancy at all concentrations in HET-CAM test 
whereas in ICE test both demonstrated slight to none 
irritancy level in light conditions. These responses 
were concentration independent in both tests. Under 
photocatalytic conditions diclofenac releases 
degradation products through various chemical 
mechanisms: photocyclisation (2-(8-chloro-9H-
carbazol-1-yl) acetic acid, 1-chloro-8-methyl-9H-
carbazole; decarboxylation (2,6-dichloro-N-o-
tolylbenzenamine); and dehalogenation. The products 
after photocyclisation are reported to cause cell lysis. 
N-centred carbazolyl radical is also formed in 
photodegradation (16). These radical intermediates 
are responsible for the phototoxic effects of diclofenac 
sodium by hydrogen abstraction from the biomolecules, 
which initiates a further toxic effect. Thus, the 
photosensitising and phototoxic properties of 
diclofenac are associated with degradation products 
produced by light exposure (23). Ketorolac 
demonstrated none to very slight irritancy in a 
concentration independent manner. Results suggest 
that no significant level of phototoxicity is achieved 
by ketorolac. In the presence of light, triplet excited 
state of ketorolac is observed, which is followed by 
oxidation (24). This single mechanism could be 
accounted for the observed very slight level of toxicity 
by ketorolac in our investigation.
Conclusion
Our findings suggest that the investigated drugs 
have phototoxicity potential at the concentrations that 
are available in the market. This investigation also 
indicates that the antibacterial agents and NSAIDs 
having phototoxic potential can be harmful, if used 
for long time. The results demonstrate that the 
analysed drugs intended for ocular use are phototoxic 
and therefore should be stored and used in dark. We 
used models which are ex-vivo in nature. The findings 
have to be validated further using more pre-clinical 
and clinical research.
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Sažetak
Fotokemijska toksičnost lijekova namijenjenih okularnoj uporabi
Cilj ovog ispitivanja bio je istražiti moguću okularnu fototoksičnost lijekova koji se koriste u oftalmološkim 
formulacijama. Sulfacetamid, ketokonazol, vorikonazol, diklofenak i ketorolak ispitivani su u 
koncentracijama koje su dostupne na tržištu u njihovom obliku koji je namijenjen za okularnu uporabu. 
Primijenjeni su testovi iritacije na kokošjem jajetu (Hen’s Egg Test Chorioallantoic Membrane - HET-
CAM), izoliranom kokošjem oku (Isolated Chicken Eye - ICE) i test hemolize crvenih krvnih stanica (Red 
Blood Cell - RBC) prema preporukama ECVAM-a, ICCVAM-a i OECD-a. Rezultati HET-CAM i ICE 
testova upućuju na umjerenu toksičnost sulfacetamida u prisutnosti svjetla/UV-A te vrlo blagu iritaciju u 
mraku. Ketokonazol i vorikonazol pokazali su blagu iritaciju u prisutnosti svjetla/UV-A te nikakvu iritaciju 
u mraku. Diklofenak i ketorolak pokazali su blagu iritaciju na svjetlu i nikakvu iritaciju u mraku. Rezultati 
upućuju na moguću toksičnost nekih od navedenih lijekova u prisutnosti svjetla. Razmjer fototoksičnosti 
može biti povećan pri produljenoj uporabi lijeka. Preporučuje se čuvati navedene lijekove na zatamnjenome 
mjestu te ih označiti odgovarajućim uputama za korištenje, osobito za osobe koje su dulje vrijeme izložene 
sunčevoj svjetlosti.
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